SEC Form 4 · accession 0001144204-15-066888
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Crockford
Other
Period of report
Nov 18, 2015
Accepted (ET)
Nov 19, 2015 · 12:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (right to buy)F1 | $0.80 | Nov 18, 2015 | A | 25,000 | A | — | Nov 18, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The Options vest at the rate of 25% per year, with the initial 25% vesting on the date of grant and 25% on each of the first, second and third anniversaries of the date of grant, respectively.
Remarks
Vice President, Regulatory Affairs, of issuer's wholly-owned subsidiary